YOLFTbeta
Taiwan Biomaterial Co., Ltd.

Taiwan Biomaterial Co., Ltd.

6649 · TWO · Healthcare / Medical Devices

35.45TWD-0.05 (-0.14%)

Price History

Full chart

Market Stats

Previous Close35.50
Open35.45
Day Range35.45 – 35.50
52-Week Range34.15 – 78.54
Volume6.21K
Market Cap1.57B
P/E (TTM)47.28
Forward P/E0.00
EPS0.79
Dividend Yield2.68%
Beta0.40
50-Day Avg35.95
200-Day Avg40.41

About

Taiwan Biomaterial Co., Ltd. engages in the development and sale of implantable medical devices in Taiwan. It provides Foamagen, a foamagen dura substitute; stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and nickel-titanium guidewire for guiding cerebral vascular surgery; tissue repair and regeneration products for the treatment of early osteoarthritis; and CDMO. The company was founded in 1921 and is based in Zhubei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Derek Ma
  • Employees46
  • HeadquartersNo. 188, Shengyi Road, Zhubei, Taiwan, 30261, Taiwan
  • Websitehttps://www.twbm.com.tw

Leadership

  • Mr. Derek MaGeneral Manager
  • Yun Quan LiAccounting Supervisor

Financials

Income Statement

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue41.67M127.31M72.84M96.57M220.40M
Growth (%)-+205.48%-42.79%+32.59%+128.22%
Cost of Revenue9.52M36.94M25.72M39.27M85.61M
Gross Profit32.15M90.37M47.12M57.31M134.80M
Gross Margin77.15%70.99%64.69%59.34%61.16%
Operating Expense88.87M64.91M61.35M68.54M73.96M
Operating Income-56.72M25.46M-14.22M-11.23M60.83M
Operating Margin-136.10%20.00%-19.53%-11.63%27.60%
EBITDA-51.63M9.71M15.99M76.30M
EBITDA Margin-40.56%13.32%16.56%34.62%
Net Income-47.44M33.76M-10.13M-1.73M58.93M
Net Income Margin-113.84%26.51%-13.91%-1.79%26.74%
R&D65.41M32.12M22.78M31.08M23.55M
R&D as % of Total Revenue156.95%25.23%31.28%32.18%10.69%
Interest Expense1.03M973.00K872.00K803.00K741.00K
Interest Expense % of Total Revenue2.47%0.76%1.20%0.83%0.34%

Balance Sheet

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets553.79M735.31M716.28M704.56M789.95M
Total Liabilities130.89M88.89M88.38M78.39M104.86M
Total Equity422.89M646.42M627.89M626.16M685.09M
Cash91.65M183.15M171.68M205.34M258.40M

Cash Flow

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-26.29M29.31M-10.16M18.43M48.77M
Capital Expenditure29.70M37.48M3.21M4.64M3.14M
Free Cash Flow-55.99M-8.17M-13.38M13.78M45.63M
Dividends Paid--8.40M--
FCF to OCF212.95%-27.87%131.60%74.80%93.56%
Dividend Paid to FCF---62.80%--

Key Statistics & Ratios

Market Cap1.57B
Enterprise Value1.29B
Trailing P/E47.28
Forward P/E0.00
Price / Sales8.60
Price / Book2.31
EPS0.79
Book Value15.33
Revenue (TTM)182.32M
Gross Profit (TTM)102.05M
EBITDA29.44M
Profit Margin18.19%
Operating Margin-8.49%
Return on Equity5.12%
Return on Assets1.59%
Shares Outstanding42.00M
Shares Float26.37M
Beta0.40
Dividend Yield2.68%
Dividend Rate1.00
Payout Ratio126.89%

Dividends

20261×
1.00Apr 9, 2026
20231×
0.20Aug 9, 2023